Patel Naimish
SEC CIK 2021679 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | Chief Medical Off | 19.4K | $49.7K | $503.9K | 7 | 2025-04-03 | 2026-05-29 |
Most active insiders at CRSP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kulkarni Samarth | CEO, Dir | — | $10.76M |
| 2 | Prasad Raju | CFO | — | $5.10M |
| 3 | KASINGER JAMES R. | GC, Sec | — | $1.27M |
| 4 | Behbahani Ali | Dir | — | $780.9K |
| 5 | Patel Naimish | Chief Medical Off | — | $362.6K |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-01 17:35 | 2026-05-28 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | M - OptEx | — | +10.0K | 23.1K | +76% | — |
| D | 2026-06-01 17:35 | 2026-05-29 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | S - Sale+OE | $55.62 | -3,786 | 19.4K | -16% | -$210.6K |
| D | 2026-03-17 | 2026-03-14 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | M - OptEx | — | +8,125 | 16.3K | +99% | — |
| D | 2026-03-17 | 2026-03-16 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | S - Sale+OE | $48.26 | -3,150 | 13.1K | -19% | -$152.0K |
| 2026-01-27 | 2025-04-03 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | P - Purchase | $32.96 | +1,508 | 1,508 | New | +$49.7K | |
| D | 2025-05-30 | 2025-05-28 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | M - OptEx | — | +10.0K | 10.0K | New | — |
| D | 2025-05-30 | 2025-05-29 | CRSP | CRISPR Therapeutics AG | Patel Naimish | Chief Medical Off | S - Sale+OE | $35.94 | -3,932 | 6,068 | -39% | -$141.3K |
Purchase Sale Sale after option exercise All abbreviations